Watchlist Price Alert

Cerevel Therapeutics Inc... (CERE)

NASDAQ: CERE · Real-Time Price · USD

44.96

0.33 (0.74%)

At close: Jul 31, 2024, 8:00 PM

Cerevel Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	-432.84M	-351.51M	-225.33M	-152.14M	-128.39M
Depreciation & Amortization	5.63M	4.9M	2.73M	397K	177K
Stock-Based Compensation	69.41M	38.78M	23.94M	10.52M	8.31M
Other Working Capital	14.08M	28.83M	8.26M	16.29M	-264K
Other Non-Cash Items	1.43M	-13.42M	694K	2.44M	2.4M
Deferred Income Tax	-2.04M	n/a	3.88M	3.27M	46.44M
Change in Working Capital	16.11M	28.06M	15.54M	17.71M	343K
Operating Cash Flow	-342.3M	-293.19M	-178.55M	-117.8M	-70.72M
Capital Expenditures	-3.81M	-3.95M	-10.5M	-18.89M	-1.1M
Cash Acquisitions	-77.53K	384.88K	n/a	n/a	n/a
Purchase of Investments	-865.27M	-887.74M	-425.16M	n/a	n/a
Sales Maturities Of Investments	942.8M	502.86M	n/a	n/a	n/a
Other Investing Acitivies	77.53K	-384.88K	-425.16K	n/a	n/a
Investing Cash Flow	73.72M	-388.83M	-435.66M	-18.89M	-1.1M
Debt Repayment	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	548.62M	623.19M	423.6M	440.83M	60.06M
Financial Cash Flow	548.62M	623.19M	423.6M	440.83M	60.06M
Net Cash Flow	98.94M	-58.83M	-190.6M	304.14M	-11.76M
Free Cash Flow	-346.11M	-297.14M	-189.05M	-136.69M	-71.82M